Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
A Brain Transplant that Works
Lancet 335:445-446, , 1990
Ethical, Palliative, and Policy Considerations in Disorders of Consciousness
Neurol 91:471-475, Fins, J.J. & Bernat, J.L., 2018
Clinicopath Conf, Oocyte Retrieval After Anoxic Brain Injury
NEJM: 363:276-283, Case 24-2010, 2010
Huntingtons Disease
BMJ 341:34-40, Novak,M.J. &Tabrizi,S.J., 2010
Neurologic Prognosis After Cardiac Arrest
NEJM 361:605-611, Young,G.B., 2009
Responding to Requests from Adult Patients for Neuroenhancements
Neurol 73:1406-1412, Larriviere,D.,et al, 2009
In Utero Magnetic Resonance Imaging for Brain and Spinal Abnormalities in Fetuses
BMJ 331:562-565, Griffiths,P.D.,et al, 2005
The Shape of Things to Come
Neurol 63:948-950, Hauser,S.L., 2004
Slippery Slopes, Wonder Drugs, and Cosmetic Neurology
Neurol 63:951-952, Dees,R.H., 2004
Cosmetic Neurology: The Controversy Over Enhancing Movement, Mentation, and Mood
Neurol 63:968-974, Chatterjee,A., 2004
Genetic Testing in Spinocerebellar Ataxias
Arch Neurol 58:191-195, Tan,E. &Ashizawa,T., 2001
The Clinical Introduction of Genetic Testing for Alzheimer Disease, An Ethical Perspective
JAMA 277:832-836, Post,S.G.,et al, 1997
Genetic Testing for Alzheimer Disease, Practical and Ethical Issues
Arch Neurol 54:1226-1229, Roses,A.D., 1997
Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996
Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996
Research Involv Subj with Dementia & Other Cognitive Impairments:NIH, & Ethical Considerations
Neurol 45:1777-1778, Wichman,A.&Sandler,A.L., 1995
Statement of Use of Apolipoprotein E Testing for Alzheimer Disease
JAMA 274:1627-1629, Farrer,L.A.,et al, 1995
The Neurogenetic Genie:Testing for Huntington's Disease Mutation
Neurol 44:1369-1373, 1533-15361994., Hersch,S.,et al, 1994
Asking the Courts to Set the Standard of Emergency Care-The Case of Baby K
NEJM 330:1542-1545, Annas,G.J., 1994
Clinical Consequences of Isolating the Gene for Huntington's Disease
BMJ 307:397-398, Harper,P.S., 1993
Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene
JAMA 270:2321-2325, Babul,R.,et al, 1993
Presymptomatic Testing for Huntington's Disease in the United Kingdom
BMJ 304:1593-1596, Tyler,A.,et al, 1992
Outlook for the Child with a Cephalocele
Pediatrics 90:914-919, Brown,M.S.,et al, 1992
Withdrawal of Life-Support from Patients in a Persistent Vegetative State
Lancet 337:96-98, Boyd,K.M., 1991
The Infant with Anencephaly
Med Task Force on Anencephaly, NEJM 322:669-6741990., , 1990
Predictive Testing for Huntington's Disease, Progress and Problems
BMJ 298:404-405, 1989, Harper,P.S.&Morris,M.J., 1989
Position of the American Academy of Neurology on Certain Aspects of the Care and Management of the Persistent Vegetative State Patient
Neurol 39:125-126, , 1989
Problems in Genetic Prediction for Huntington's Disease
Lancet 2:601-603, Morris,M.J.,et al, 1989